Luedi Rudolf, Hsieh Kety, Slezak Agnieszka, El-Koussy Marwan, Fischer Urs, Heldner Mirjam R, Meisterernst Julia, Mono Marie-Luise, Zubler Christoph, Mordasini Pasquale, Ozdoba Christoph, Mattle Heinrich P, Schroth Gerhard, Gralla Jan, Arnold Marcel, Jung Simon
Department of Neurology, Inselspital, University Hospital Bern and University of Bern, Freiburgstrasse 10, 3010, Bern, Switzerland.
J Neurol. 2014 Aug;261(8):1622-7. doi: 10.1007/s00415-014-7401-0. Epub 2014 Jun 11.
Elderly patients generally experience less favorable outcomes and higher mortality after acute stroke than younger patients. The aim of this study was to analyze the influence of age on outcome and safety after endovascular therapy in a large cohort of patients aged between 20 and 90 years. We prospectively acquired data of 1,000 stroke patients treated with endovascular therapy at a single center. Logistic regression analysis was performed to determine predictors of outcome and linear regression analysis to evaluate the association of age and outcome after 3 months. Younger age was an independent predictor of favorable outcome (OR 0.954, p < 0.001) and survival (OR 0.947, p < 0.001) in multivariate regression analysis. There was a linear relationship between age and outcome. Ever increase in 26 years of age was associated with an increase in the modified Rankin Scale of 1 point (p < 0.001). However, increasing age was not a risk factor for symptomatic (p = 0.086) or asymptomatic (p = 0.674) intracerebral hemorrhage and did not influence recanalization success (p = 0.674). Advancing age was associated with a decline of favorable outcomes and survival after endovascular therapy. This decline was linear from age 20 to 90 years, but was not related to lower recanalization rates or higher bleeding risk in the elderly. The efficacy of endovascular stroke therapy seems to be preserved also in the elderly and other factors than efficacy of endovascular therapy such as decreased plasticity are likely to explain the worse outcome with advancing age.
老年患者急性卒中后的预后通常比年轻患者更差,死亡率更高。本研究的目的是分析年龄对20至90岁的一大群患者血管内治疗后预后和安全性的影响。我们前瞻性地收集了在单一中心接受血管内治疗的1000例卒中患者的数据。进行逻辑回归分析以确定预后的预测因素,并进行线性回归分析以评估3个月后年龄与预后的关联。在多变量回归分析中,较年轻的年龄是良好预后(OR 0.954,p < 0.001)和生存(OR 0.947,p < 0.001)的独立预测因素。年龄与预后之间存在线性关系。年龄每增加26岁,改良Rankin量表评分增加1分(p < 0.001)。然而,年龄增加不是有症状(p = 0.086)或无症状(p = 0.674)脑出血的危险因素,也不影响再通成功率(p = 0.674)。年龄增长与血管内治疗后良好预后和生存的下降有关。从20岁到90岁,这种下降呈线性,但与老年人较低的再通率或较高的出血风险无关。血管内卒中治疗的疗效在老年人中似乎也得以保留,血管内治疗疗效以外的其他因素如可塑性降低可能解释了随着年龄增长预后更差的原因。